动物治疗和诊断市场规模、份额和成长分析（按产品、技术、应用、动物种类、最终用途和地区划分）－2026-2033年产业预测

全球兽医治疗和诊断市场规模预计在 2024 年达到 502.8 亿美元，从 2025 年的 534.5 亿美元增长到 2033 年的 871.4 亿美元，在预测期（2026-2033 年）内复合年增长率为 6.3%。

在技​​术创新、监管标准日益严格以及对动物健康解决方案需求不断增长的推动下，全球动物治疗诊断市场正经历显着增长。产业领导者和研究人员正优先开发智慧诊断系统并整合人工智慧技术，以提高效能并简化供应链流程。机器学习和人工智慧的持续进步正在改变动物健康数据的传播方式，从而能够针对特定物种、健康状况和监管要求提供超精准的即时建议。这项技术变革不仅提高了诊断的准确性和效率，还有助于更快、更有效地进行动物健康管理，为未来市场的持续发展和创新奠定了基础。

推动全球动物治疗诊断市场发展的因素

受人们对伴侣动物观念转变的推动，全球兽医治疗和诊断市场正经历显着成长。宠物越来越被视为家庭成员，尤其是在北美、欧洲和亚太地区。这种转变推动了对动物健康的高级治疗和诊断解决方案的需求。已开发国家拥有较高的可支配收入，正加速采用创新护理方案；而在开发中国家，饲主数量的增加也促使人们提高照护标准。这两种趋势共同推动了兽医保健产业的市场扩张和创新。

全球动物治疗和诊断市场面临的限制因素

全球兽医治疗和诊断市场面临严峻挑战，这主要是由于生物製药、细胞疗法等先进治疗技术以及精密诊断技术的前期成本高昂。这种经济负担会限制市场成长，尤其会影响发展中地区的小规模独立兽医诊所和机构。因此，这些高效解决方案的应用往往仅限于大规模兽医医院网路和研究机构。除非出现更具扩充性和成本效益的创新技术，否则市场可能无法充分发挥其潜力，从而限制更多医疗保健专业人员获得这些先进的治疗方法和诊断工具。

全球动物治疗与诊断市场趋势

全球动物治疗诊断市场正日益受到旨在提升动物健康管理的数位化平台的推动。先进数位工具的整合正在透过提高效率和改善诊断准确性来改变传统的兽医实践。这一趋势在伴侣动物和畜牧管理领域尤其明显，这主要得益于宠物科技解决方案的广泛应用。随着相关人员逐渐认识到互联智慧兽医解决方案的价值，对创新诊断技术的需求预计将会成长。这将有助于制定更积极主动的健康管理和治疗策略，从而重塑动物医疗保健的提供方式。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术评估
• 监管环境
• 客户和购买标准分析

全球动物治疗和诊断市场规模（按产品和复合年增长率划分）（2026-2033 年）

• 消耗品
• 装置

全球动物治疗及诊断市场规模（依技术及复合年增长率划分）（2026-2033 年）

• 临床生物化学
  • 血糖监测
  • 血气和电解质分析
  • 其他临床生物化学检验
• 免疫诊断
  • 横向流动化验
  • ELISA
  • 免疫检测装置
  • 其他免疫诊断测试
• 分子诊断
  • PCR
  • 微阵列
  • 其他分子诊断测试
• 血液学
• 尿液检查
• 其他技术

全球动物治疗及诊断市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 细菌学
• 病理
• 寄生虫学
• 其他用途

全球动物治疗及诊断市场规模（按动物类型划分）及复合年增长率（2026-2033 年）

• 伴侣动物
  • 狗
  • 猫
  • 马
  • 其他伴侣动物
• 家畜
  • 牛
  • 猪
  • 家禽
  • 其他家畜

全球动物治疗和诊断市场规模（按最终用途和复合年增长率划分）（2026-2033 年）

• 兽医医院和诊所
• 诊断检查室
• 居家医疗环境
• 其他用途

全球动物治疗及诊断市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Zoetis（USA）
• Merck Animal Health（USA）
• Boehringer Ingelheim（Germany）
• Elanco（USA）
• IDEXX Laboratories（USA）
• Virbac（France）
• Ceva Sante Animale（France）
• Dechra Pharmaceuticals（UK）
• Vetoquinol（France）
• Phibro Animal Health（USA）
• Heska Corporation（USA）
• Neogen（USA）
• Covetrus（USA）
• Thermo Fisher Scientific（USA）
• ImmuCell（USA）
• B. Braun Vet Care（Germany）
• Huvepharma（Bulgaria）
• Indian Immunologicals Limited（India）
• Zoetis Animal Health India Pvt. Ltd.（India）
• Inmed Animal Health（India）

结论与建议

Global Animal Therapeutics Diagnostics Market size was valued at USD 50.28 Billion in 2024 and is poised to grow from USD 53.45 Billion in 2025 to USD 87.14 Billion by 2033, growing at a CAGR of 6.3% during the forecast period (2026-2033).

The global animal therapeutics diagnostics market is experiencing significant growth due to technological innovation, heightened regulatory standards, and a rising demand for animal health solutions. Industry leaders and researchers are prioritizing the development of intelligent diagnostic systems and the integration of AI-driven technologies to enhance performance and streamline supply chain processes. Continued advancements in machine learning and artificial intelligence are transforming the dissemination of animal health data, allowing for hyper-targeted, real-time recommendations tailored to specific species, health conditions, and regulatory requirements. This evolution in technology is not only improving diagnostic accuracy and efficiency but also fostering a more responsive and effective approach to animal health management, positioning the market for sustained progress and innovation in the future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Animal Therapeutics Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Animal Therapeutics Diagnostics Market Segments Analysis

Global Animal Therapeutics Diagnostics Market is segmented by Product, Technology, Application, Animal Type, End Use and region. Based on Product, the market is segmented into Consumables and Instruments. Based on Technology, the market is segmented into Clinical biochemistry, Immunodiagnostics, Molecular diagnostics, Hematology, Urinalysis and Other technologies. Based on Application, the market is segmented into Bacteriology, Pathology, Parasitology and Other applications. Based on Animal Type, the market is segmented into Companion animals and Farm animals. Based on End Use, the market is segmented into Veterinary hospitals and clinics, Diagnostic labs, Home care settings and Other end use. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Animal Therapeutics Diagnostics Market

The Global Animal Therapeutics Diagnostics market is experiencing significant growth driven by an evolving perception of companion animals. Pets are increasingly regarded as integral members of the family, particularly in regions such as North America, Europe, and Asia-Pacific. This shift has led to heightened demand for advanced therapeutics and diagnostics solutions tailored to animal health. In developed countries with greater disposable incomes, there is a robust adoption of innovative care options, while in developing nations, the growing pet population is prompting owners to enhance their care standards. This dual dynamic propels market expansion and innovation within the animal health sector.

Restraints in the Global Animal Therapeutics Diagnostics Market

The Global Animal Therapeutics Diagnostics market faces notable challenges due to the substantial upfront costs associated with advanced therapeutics, such as biologics and cell-based therapies, along with sophisticated diagnostic technologies. This financial burden can restrict market growth, particularly impacting smaller independent veterinary clinics and veterinary practices in developing regions. Consequently, the adoption of these high-efficacy solutions tends to be largely confined to larger veterinary hospital networks and research facilities. Without the emergence of more scalable and cost-effective innovations, the market might struggle to achieve its full potential, limiting access to these advanced treatments and diagnostic tools for a broader range of practitioners.

Market Trends of the Global Animal Therapeutics Diagnostics Market

The Global Animal Therapeutics Diagnostics market is increasingly influenced by the surge in digital platforms aimed at enhancing animal health management. The integration of advanced digital tools is transforming traditional veterinary practices by promoting efficiency and improving diagnostic accuracy. This trend is particularly pronounced in both companion animal and livestock management sectors, driven by the growing adoption of pet-tech solutions. As stakeholders recognize the value of connected, smart veterinary solutions, the demand for innovative diagnostic technologies is expected to rise, facilitating more proactive health management and treatment strategies, thereby reshaping the landscape of animal healthcare delivery.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape
• Customer & Buying Criteria Analysis

Global Animal Therapeutics Diagnostics Market Size by Product & CAGR (2026-2033)

• Market Overview
• Consumables
• Instruments

Global Animal Therapeutics Diagnostics Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Clinical biochemistry
  • Glucose monitoring
  • Blood gas and electrolyte analysis
  • Other clinical biochemistry tests
• Immunodiagnostics
  • Lateral flow assays
  • ELISA
  • Immunoassay analyzers
  • Other immunodiagnostic tests
• Molecular diagnostics
  • PCR
  • Microarrays
  • Other molecular diagnostic tests
• Hematology
• Urinalysis
• Other technologies

Global Animal Therapeutics Diagnostics Market Size by Application & CAGR (2026-2033)

• Market Overview
• Bacteriology
• Pathology
• Parasitology
• Other applications

Global Animal Therapeutics Diagnostics Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Companion animals
  • Dogs
  • Cats
  • Horses
  • Other companion animals
• Farm animals
  • Cattle
  • Swine
  • Poultry
  • Other farm animals

Global Animal Therapeutics Diagnostics Market Size by End Use & CAGR (2026-2033)

• Market Overview
• Veterinary hospitals and clinics
• Diagnostic labs
• Home care settings
• Other end use

Global Animal Therapeutics Diagnostics Market Size & CAGR (2026-2033)

• North America (Product, Technology, Application, Animal Type, End Use)
  • US
  • Canada
• Europe (Product, Technology, Application, Animal Type, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Application, Animal Type, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Application, Animal Type, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Application, Animal Type, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDEXX Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Pharmaceuticals (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phibro Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heska Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Covetrus (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ImmuCell (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Vet Care (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Huvepharma (Bulgaria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indian Immunologicals Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis Animal Health India Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inmed Animal Health (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations